This study also detected associations between DcR3 gene polymorphisms and the clinicopathological features of breast IDC, including lymph node metastasis and C-erbB2, P53, estrogen receptor and progesterone receptor status. This evidence concerns the gene TP53 and metastatic malignant neoplasm in the lymph nodes.